The United States leads significantly in the global top 10% cited scientific publications in nursing oncology, with 28.21 publications. China and the United Kingdom follow, though considerably behind, at 5.85 and 5.76 publications, respectively. Australia and Canada round out the top five. Over the last year, the United Kingdom and Australia saw notable increases of 14.19% and 17.58%, while the US grew by a modest 2.57%. Switzerland's output surged by 103.36% and Belgium by 134.09%, showcasing potential as emerging contributors. Canada and Norway experienced declines of 4.57% and 18.72%, respectively. These variations reflect diverse growth dynamics across countries.
Future trends to watch include potential sustained growth in Switzerland and Belgium, driven by recent substantial increases. Nations like China, South Korea, and India are likely to boost their contributions, with current growth rates quite robust. Monitoring shifts among emerging economies and their impact on global dynamics is crucial, as previously underrepresented countries might elevate their status through increased research collaborations and investments in oncology nursing fields.
Top countries in Total Number of 10% Top-Cited Scientific Publications in Nursing Oncology by Country
| # | 10 Countries | Units (Publications) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 28.21 | 2023 | +4.49% | +2.57% | View data |
| 2 | 2 China | 5.85 | 2023 | +7.56% | +10.05% | View data |
| 3 | 3 United Kingdom | 5.76 | 2023 | +3.25% | +14.19% | View data |
| 4 | 4 Australia | 4.67 | 2023 | +5.15% | +17.58% | View data |
| 5 | 5 Canada | 3 | 2023 | +0.066% | -4.57% | View data |
| 6 | 6 Netherlands | 2.86 | 2023 | +5.24% | +4.15% | View data |
| 7 | 7 India | 2.78 | 2023 | +6.6% | +13.15% | View data |
| 8 | 8 South Korea | 1.39 | 2023 | +1.23% | +22.63% | View data |
| 9 | 9 Spain | 1.34 | 2023 | +20.36% | +6.06% | View data |
| 10 | 10 Germany | 1.22 | 2023 | +6.56% | +4.01% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...